Lindsay Strowd to Biological Products
This is a "connection" page, showing publications Lindsay Strowd has written about Biological Products.
Connection Strength
0.997
-
Guda A, Feldman SR, Strowd L. Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon. Expert Opin Investig Drugs. 2018 11; 27(11):931-939.
Score: 0.577
-
Ghamrawi R, Bell KA, Balogh EA, Strowd LC, Feldman SR. Current and emerging biologics for the treatment of pediatric atopic dermatitis. Expert Opin Biol Ther. 2020 12; 20(12):1435-1445.
Score: 0.167
-
Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
Score: 0.144
-
Strowd LC, Yentzer BA, Fleischer AB, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar; 60(3):478-81.
Score: 0.073
-
Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
Score: 0.037